<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>AI Drug Discovery on Expert LinkedIn</title>
    <link>https://expertlinked.in/tags/ai-drug-discovery/</link>
    <description>Recent content in AI Drug Discovery on Expert LinkedIn</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <copyright>Copyright © ExpertLinkedIn</copyright>
    <lastBuildDate>Tue, 07 Apr 2026 00:00:00 +0800</lastBuildDate><atom:link href="https://expertlinked.in/tags/ai-drug-discovery/index.xml" rel="self" type="application/rss+xml" />
    
    <item>
      <title>AI Drug Discovery Solved the Easy Problem. Now Comes the Hard One.</title>
      <link>https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/</link>
      <pubDate>Tue, 07 Apr 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/</guid>
      <description>AI drug discovery&amp;rsquo;s 80-90% Phase I success rate is real. But Phase I mostly measures toxicity. The industry is betting billions on a revolution whose hardest proof is still outstanding.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/featured.webp" />
    </item>
    
  </channel>
</rss>
